Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer

Clinical trial NCT04620603 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04620603
Sponsor: Case Comprehensive Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Cutaneous Malignant Melanoma Renal Cell Cancer Urothelial Cancer of Renal Pelvis

Start date: 2021-05-27
Primary completion: 2024-03-20
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.